Article Text

other Versions

PDF
Subcutaneous furosemide in patients with refractory heart failure
  1. Ainara Lozano Bahamonde,
  2. Vanessa Escolar Pérez,
  3. Alain Laskibar Asua,
  4. María Rodríguez Rodríguez and
  5. Nekane Murga Eizagaechevarria
  1. Department of Cardiology, Organizacion Sanitaria Integrada Bilbao Basurto, Bilbao, Spain
  1. Correspondence to Ainara Lozano Bahamonde, Organizacion Sanitaria Integrada Bilbao Basurto, Bilbao 48013, Spain; ainaralozano{at}hotmail.com

Statistics from Altmetric.com

Introduction

Resistance to oral diuretics limits the optimisation of diuretic treatment in patients with congestive heart failure (HF).1 2 Publications on the use of subcutaneous furosemide for treatment of HF are scarce, not being experience regarding its use as long-term treatment.3–5

Methods

We carried out a descriptive study based on the follow-up of patients with HF and congestive decompensations in our hospital from October 2014 to May 2018 with subcutaneous furosemide administrated by elastomeric pumps. The inclusion criteria were patients with decompensated HF without response to oral diuretics, frequent hospital admissions or repetitive use of intravenous treatment at home. The …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.